ライフサイエンスコーパス: Enterobacter

1 t may be subject to limitations when testing Enterobacter.

2 cteria including Pseudomonas, Shewanella and Enterobacter.

3 lus influenzae (19%), Pseudomonas (11%), and Enterobacter (11%).

4 this test using PB against larger numbers of Enterobacter A total of 143 nonduplicate Enterobacter is

5 acter cloacae (21), Acinetobacter spp. (13), Enterobacter aerogenes (11), Citrobacter spp. (10), Pseu

6 ter spp. (6.2%), Serratia marcescens (5.5%), Enterobacter aerogenes (4.4%), Stenotrophomonas maltophi

7 actam (<1% difference) for 6,938 isolates of Enterobacter aerogenes and 13,954 isolates of Enterobact

8 selectivity of the method was examined with Enterobacter aerogenes and Enterobacter dissolvens, whic

9 seudomonas species, Serratia marcescens, and Enterobacter aerogenes in most of the trials.

10 Glycerophosphodiesterase (GpdQ) from Enterobacter aerogenes is a nonspecific diesterase that

11 The mechanism of action against Enterobacter aerogenes of one of the most efficient of t

12 there was a well-founded proposal to rename Enterobacter aerogenes to Klebsiella aerogenes, based on

13 Enterobacter aerogenes VCs lead to growth inhibition and

14 Enterobacter aerogenes was recently renamed Klebsiella a

15 robacterium tumifaciens, Salmonella setubal, Enterobacter aerogenes) strains.

16 mmon CRE species were Klebsiella pneumoniae, Enterobacter aerogenes, and Escherichia coli.

17 the human pathogens Klebsiella pneumonia and Enterobacter aerogenes, and would seem to suggest a subc

18 Escherichia coli, Citrobacter freundii, and Enterobacter aerogenes, as well as Gram-positive Bacillu

19 c media prepared with live or dead bacteria (Enterobacter aerogenes, E. coli, Klebsiella pneumoniae,

20 um cephalosporin-resistant Escherichia coli, Enterobacter aerogenes, Enterobacter cloacae complex, Kl

21 ium, Serratia marcescens, Shigella flexneri, Enterobacter aerogenes, Klebsiella pneumoniae, Yersinia

22 oniae ACT-1, and the AmpC beta-lactamases of Enterobacter aerogenes, Morganella morganii, and Citroba

23 several bacteria, such as Escherichia coli, Enterobacter aerogenes, Pseudomonas aeruginosa and Salmo

24 rains of E. coli, Klebsiella pneumoniae, and Enterobacter aerogenes.

25 an IncPbeta plasmid previously isolated from Enterobacter aerogenes.

26 Candida albicans, as well as Pseudomonas and Enterobacter aerogenes.

27 90 Enterobacter cloacae, and one (1%) of 162 Enterobacter aerogenes.

28 oculated onto nonnutrient agar overlaid with Enterobacter aerogenes.

29 Proteus mirabilis, Citrobacter freundii and Enterobacter agglomerans [cyclo(DeltaAla-L-Val) only].

30 Citrobacter freundii, Klebsiella pneumoniae, Enterobacter agglomerans, and Shigella spp.

31 nism include its biochemical similarities to Enterobacter agglomerans, its apparent ability to cause

32 ross-reactivity from Salmonella enteritidis, Enterobacter agglomerans, Pseudomonas putida, Staphyloco

33 es are related to the chromosomal enzymes of Enterobacter and Citrobacter spp. and also mediate resis

34 Our results indicate that the combination of Enterobacter and Comamonas strains with the production o

35 ospital environment (including Enterococcus, Enterobacter and Klebsiella species), in babies delivere

36 sion of diverse strains of bla(KPC)-carrying Enterobacter and Klesbiella, with evidence that most der

37 Plasmids from Enterobacter and other taxa had a higher prevalence of m

38 amide resistance, sul1 was more common among Enterobacter and other taxa, compared to sul2 and sul3 f

39 lococcus and in FRI, the most pathogens were Enterobacter and Pseudomonas.

40 4)(+) enriched Pseudomonas, Flavisolibacter, Enterobacter and Pseudoxanthomonas in the first week and

41 Enterobacter and Serratia proliferation was impeded in t

42 In contrast, Enterobacter and/or Pseudomonas were isolated primarily

43 resistant enterococci, ceftriaxone-resistant Enterobacter , and carbapenem-resistant Enterobacterales

44 trogenesis by members of the genera Vibrio , Enterobacter , and Citrobacter and by Bacillus stratosph

45 25% of individual species of Acinetobacter, Enterobacter, and coagulase-negative staphylococci recov

46 ntly caused by Enterococcus, Staphylococcus, Enterobacter, and Klebsiella.

47 eat that CO cannot differentiate Klebsiella, Enterobacter, and Serratia spp., enteric pathogens were

48 rial genera, including Salmonella, Yersinia, Enterobacter, and species of the plant pathogen, Erwinia

49 Members of the genus Enterobacter are commensal organisms of the gastrointest

50 he genera Stenotrophomonas, Pseudomonas, and Enterobacter are responsible for defense suppression.

51 a (27.5%), Enterobacter cloacae (16.8%), and Enterobacter asburiae (10.7%) were the most predominant

52 identified genus was most closely related to Enterobacter asburiae.

53 Enterobacter bacteremia, invasive aspergillosis, and dis

54 We have identified an Enterobacter bacterium isolated from wild mosquito popul

55 isolates representing Enterobacter cloacae, Enterobacter bugandensis, Enterobacter kobei, Enterobact

56 ia, Bacillus, Pseudomonas, Serratia, Hafnia, Enterobacter, Citrobacter, and Lactobacillus.

57 the intracellular trafficking of a subset of Enterobacter clinical isolates, including colistin-resis

58 om 1.1-log to > 8 log (Klebsiella aerogenes, Enterobacter cloaca, Staphylococcus hominis) even for hi

59 i (14.3%), Klebsiella pneumoniae (10.9%) and Enterobacter cloacae (16.3%) were the main MDRE species

60 Pseudomonas aeruginosa (27.5%), Enterobacter cloacae (16.8%), and Enterobacter asburiae

61 m patients were Pseudomonas aeruginosa (22), Enterobacter cloacae (21), Acinetobacter spp. (13), Ente

62 coli (18.8%), Klebsiella pneumoniae (14.2%), Enterobacter cloacae (9.1%), Acinetobacter spp. (6.2%),

63 hogens with interpretive criteria, excluding Enterobacter cloacae (98.3% S) and E. faecalis (86.0% S)

64 m Staphylococcus aureus, and aac(3)-VIa from Enterobacter cloacae (conferring resistance to kanamycin

65 type VI secretion system (T6SS) activity in Enterobacter cloacae (ECL).

66 (n = 1,127), Escherichia coli (n = 149), and Enterobacter cloacae (n = 110).

67 moniae (n = 236), Escherichia coli (n = 22), Enterobacter cloacae (n = 23), Klebsiella oxytoca (n = 8

68 ther Staphylococcus epidermidis (n = 100) or Enterobacter cloacae (n = 60).

69 1.9%), Escherichia coli (n = 129, 30.0%) and Enterobacter cloacae (n = 62, 14.4%) were the main Enter

70 The oxygen-insensitive nitroreductase from Enterobacter cloacae (NR) catalyzes two-electron reducti

71 ia coli, 0.25/1; Klebsiella pneumoniae, 2/4; Enterobacter cloacae 1/4; and Stenotrophomonas maltophil

72 a transmission cluster of blaKPC-2-positive Enterobacter cloacae among patients treated in a highly

73 linically important enzymes CTX-M-15, KPC-2, Enterobacter cloacae AmpC, Pseudomonas aeruginosa AmpC,

74 usly determined for the class C enzymes from Enterobacter cloacae and Citrobacter freundii.

75 rial cell wall biosynthetic enzyme MurA from Enterobacter cloacae and Escherichia coli in vitro.

76 A case of ventriculitis due to Enterobacter cloacae and Pseudomonas fulva following pla

77 microbial bacteremia, and seven of these had Enterobacter cloacae and S. marcescens in the same cultu

78 stant (IC(50), approximately 10,000 nM), and Enterobacter cloacae and Serratia marcescens were highly

79 L49 antibodies were chemically conjugated to Enterobacter cloacae beta-lactamase (bL), and their abil

80 Here, we discover Enterobacter cloacae CD-NTase-associated protein 4 (Cap4

81 treptococcus pneumoniae (10/11 [90.9%]), and Enterobacter cloacae complex (2/4 [50%]).

82 ively enrolled patients with K. aerogenes or Enterobacter cloacae complex (Ecc) BSI from 2002 to 2015

83 The Enterobacter cloacae complex (ECC) consists of closely r

84 sis (n = 117), Escherichia coli (n = 75) and Enterobacter cloacae complex (n = 57) also detected.

85 nd the increasing clinical importance of the Enterobacter cloacae complex have often been discussed.

86 nt Escherichia coli, Enterobacter aerogenes, Enterobacter cloacae complex, Klebsiella pneumoniae, or

87 s following induction of the SOS response in Enterobacter cloacae decreased the amount of DNA measura

88 As in other bacterial species, Enterobacter cloacae form macroscopic aggregates.

89 The Enterobacter cloacae GC1 enzyme is an example of a class

90 The crystallographic structure of the Enterobacter cloacae GC1 extended-spectrum class C beta-

91 structure of the nitroreductase enzyme from Enterobacter cloacae has been determined for the oxidize

92 Enterobacter cloacae has been implicated as one of the c

93 Recently, enteric commensal bacteria Enterobacter cloacae has been recognized as a helper in

94 rganisms, intraocular infection secondary to Enterobacter cloacae infection is a devastating disease

95 ch has best been described in the context of Enterobacter cloacae infections.

96 Enterobacter cloacae is a clinically important Gram-nega

97 Enterobacter cloacae is a Gram-negative nosocomial human

98 We describe an Enterobacter cloacae isolate harbouring a minor subpopul

99 present in K. oxytoca, Escherichia coli, and Enterobacter cloacae isolates from unlinked patients wit

100 Enterobacter cloacae isolates were resistant to all firs

101 iae isolates, 3 Escherichia coli isolates, 5 Enterobacter cloacae isolates, 2 S. marcescens isolates,

102 the x-ray structures of the D305A mutant of Enterobacter cloacae MurA and the D313A mutant of Escher

103 tured and depicted the Cys-115-PEP adduct of Enterobacter cloacae MurA in various reaction states by

104 ablished that Cys115 of Escherichia coli and Enterobacter cloacae MurA is the active site nucleophile

105 s been determined to be 8.3, by titration of Enterobacter cloacae MurA with the alkylating agent iodo

106 d the x-ray structure of the C115S mutant of Enterobacter cloacae MurA, which was crystallized in the

107 ies of the flavin mononucleotide cofactor of Enterobacter cloacae nitroreductase (NR), determined und

108 A library of Enterobacter cloacae P99 beta-lactamase mutants was prod

109 ed reaction, cephalosporin hydrolysis by the Enterobacter cloacae P99 cephalosporinase (beta-lactam h

110 dase of Streptomyces sp. R61, a PBP, and the Enterobacter cloacae P99 cephalosporinase, a class C bet

111 inhibition of the class C beta-lactamase of Enterobacter cloacae P99 determined.

112 e) inactivates the class C beta-lactamase of Enterobacter cloacae P99 in a covalent fashion.

113 to react with the class C beta-lactamase of Enterobacter cloacae P99 in two ways, by acylation and b

114 stants for hydrolysis by beta-lactamase from Enterobacter cloacae P99 indicated kcat values of 476 +/

115 The class C beta-lactamase of Enterobacter cloacae P99 is closely similar in structure

116 The class C beta-lactamase of Enterobacter cloacae P99 is competitively inhibited by l

117 The class C serine beta-lactamase of Enterobacter cloacae P99 is irreversibly inhibited by O-

118 cts on V/K for the class C beta-lactamase of Enterobacter cloacae P99 suggest an acyl-transfer transi

119 The class C beta-lactamase of Enterobacter cloacae P99 was employed.

120 hibited typical class A (TEM-2) and class C (Enterobacter cloacae P99) beta-lactamases in a time-depe

121 , catalyzed by the class C beta-lactamase of Enterobacter cloacae P99, have been studied in order to

122 -2 antibody detected Escherichia coli CMY-2, Enterobacter cloacae P99, Klebsiella pneumoniae ACT-1, a

123 nactivators of the class C beta-lactamase of Enterobacter cloacae P99.

124 by class C beta-lactamases such as that from Enterobacter cloacae P99.

125 omyces R61 and the class C beta-lactamase of Enterobacter cloacae P99.

126 rally very similar class C beta-lactamase of Enterobacter cloacae P99.

127 on with K. pneumoniae, Proteus mirabilis, or Enterobacter cloacae promoted greater recruitment of neu

128 The membrane-bound selenate reductase of Enterobacter cloacae SLD1a-1 is purified in low yield an

129 Enterobacter cloacae strain G6809 with reduced susceptib

130 C beta-lactamase from a clinical isolate of Enterobacter cloacae strain GC1 with improved hydrolytic

131 fication of a Shiga toxin 1 (Stx1)-producing Enterobacter cloacae strain, M12X01451, from a human cli

132 nterobacter aerogenes and 13,954 isolates of Enterobacter cloacae tested using a Vitek system; for th

133 ing the melibiose-H(+) symporter (MelY) from Enterobacter cloacae that had enhanced fermentation on 1

134 rates higher than the totals were noted with Enterobacter cloacae versus ampicillin-sulbactam, aztreo

135 e given 1 x 10(6) colony-forming units/mL of Enterobacter cloacae with the third feeding.

136 bacteria (that is, Klebsiella pneumoniae and Enterobacter cloacae) and their corresponding antimicrob

137 LY]) and Enterobacter lignolyticus (formerly Enterobacter cloacae) SCF1 (enterolysin [ELY]).

138 lysaccharides (e.g., Helicobacter pylori and Enterobacter cloacae), revealing it to be a promising pr

139 er inoculation of their endophytic bacteria (Enterobacter cloacae).

140 inst Escherichia coli, Klebsiella pneumonia, Enterobacter cloacae, Acinetobacter baumannii, and methi

141 luding Escherichia coli, Citrobacter koseri, Enterobacter cloacae, and clinical isolates of non-typho

142 348 Klebsiella pneumoniae, one (<1%) of 890 Enterobacter cloacae, and one (1%) of 162 Enterobacter a

143 d -negative strains), Klebsiella pneumoniae, Enterobacter cloacae, and Pseudomonas aeruginosa.

144 a: Escherichia coli, Pseudomonas aeruginosa, Enterobacter cloacae, and Yersinia enterocolitica.

145 erved, while ETEST FO should not be used for Enterobacter cloacae, because of low EA and a high VME r

146 d of clinically significant AmpC production (Enterobacter cloacae, Citrobacter freundii, and Klebsiel

147 oci from isolates of Serratia marcescens and Enterobacter cloacae, demonstrating the presence of in-f

148 cytosis of 11 clinical isolates representing Enterobacter cloacae, Enterobacter bugandensis, Enteroba

149 y Citrobacter freundii, Clostridium species, Enterobacter cloacae, Enterococcus faecalis, Klebsiella

150 fied in the Enterobacteria Escherichia coli, Enterobacter cloacae, Erwinia herbicola, and Salmonella

151 ing probes for pathogenic bacteria including Enterobacter cloacae, Escherichia coli J96, Pseudomonas

152 isolates of important Gram-negative species-Enterobacter cloacae, Escherichia coli, Klebsiella pneum

153 several gram-negative bacteria, specifically Enterobacter cloacae, Pseudomonas aeruginosa, and Pantoe

154 ed with the P solubilizing bacterial strains Enterobacter cloacae, Pseudomonas pseudoalcaligenes, and

155 , invasive aspergillosis (20%, 3 of 15), and Enterobacter cloacae, Serratia marcescens, Pneumocystis

156 mis, E. coli O157:H7, Klebsiella pneumoniae, Enterobacter cloacae, Shigella dysenteriae, Salmonella e

157 neage - accumulates LDs when challenged with Enterobacter cloacae, Sindbis, and Dengue viruses.

158 erial species such as Klebsiella pneumoniae, Enterobacter cloacae, Stenotrophomonas maltophilia, and

159 gle D(H) gene segment (D-limited mice), with Enterobacter cloacae.

160 onse to alpha-1,3 dextran (DEX) expressed on Enterobacter cloacae.

161 ence analysis revealed that the organism was Enterobacter cloacae.

162 antibiotic for treatment of infections with Enterobacter cloacae.

163 robacter koseri but 97.0% similar to that of Enterobacter cloacae.

164 d by blood feeding, restored the immunity to Enterobacter cloacae.

165 illus, which most laboratories recognized as Enterobacter cloacae.

166 escens after injection of prepupae with live Enterobacter cloacae.

167 unique collective behaviors of the bacteria Enterobacter cloacae.

168 deployed by the type VI secretion system of Enterobacter cloacae.

169 sistance (AMR) are Klebsiella pneumoniae and Enterobacter cloacae.

170 hich is identical to plasmid pNDM-HF727 from Enterobacter cloacae.

171 Escherichia coli, Klebsiella pneumoniae and Enterobacter cloacae/E. cloacae complex, the most common

172 t on four cases of endophthalmitis caused by Enterobacter cloacae: two in patients with acute postope

173 a/BMP signaling turned a normally beneficial Enterobacter commensal to pathogenic.

174 Enterobacter commensals are common in the worm gut, cont

175 was examined with Enterobacter aerogenes and Enterobacter dissolvens, which did not produce any signi

176 a decrease in Clostridium and an increase in Enterobacter, Escherichia/Shigella, and Pseudomonas in s

177 cus, Klebsiella, Acinetobacter, Pseudomonas, Enterobacter (ESKAPE), and other enteric pathogens to re

178 the Escherichia, Salmonella, Klebsiella, and Enterobacter genera possess only a single LuxR homolog,

179 ropionibacterium, Clostridium, Borrelia, and Enterobacter genera; and a major reorganization of the f

180 rs of the genera Escherichia, Klebsiella and Enterobacter, genera commonly associated with nosocomial

181 lla pneumoniae carbapenemase (KPC)-producing Enterobacter gergoviae.

182 osa, Enterocococcus spp., and the Klebsiella-Enterobacter group.

183 o carbapenem and colistin, illustrating that Enterobacter has a large arsenal of mechanisms to grow u

184 s, indole-positive Proteus, Citrobacter, and Enterobacter) has served as a reminder to consider when

185 r xiangfangensis, Enterobacter roggenkampii, Enterobacter hoffmannii, and Enterobacter ludwigii was i

186 essed the virulence of contemporary clinical Enterobacter hormaechei isolates in a mouse model of int

187 8, and clonal expansion of bla(KPC)-carrying Enterobacter hormaechei ST171, primarily at a single foc

188 Klebsiella pneumoniae, Enterobacter hormaechei, Acinetobacter baumannii, Serrat

189 Escherichia coli, Citrobacter freundii, and Enterobacter hormaechei.

190 l samples included Enterococcus faecalis and Enterobacter hormaechei.

191 Carbapenems are recommended for treatment of Enterobacter infections with AmpC phenotypes.

192 describe the isolation and identification of Enterobacter intermedium from the gallbladder of a patie

193 Enterobacter is a globally important pathogen.

194 of Enterobacter A total of 143 nonduplicate Enterobacter isolates (102 E. cloacae complex, 41 E. aer

195 Enterobacter isolates did not replicate in human macroph

196 ose possessing Enterococcus, Klebsiella, and Enterobacter isolates from field-collected larvae.

197 One hundred four Enterobacter isolates were tested by standard CLSI disk

198 Of 143 Enterobacter isolates, 25 were determined to be PB resis

199 erobacter cloacae, Enterobacter bugandensis, Enterobacter kobei, Enterobacter xiangfangensis, Enterob

200 del 1981 (DSM 2032) (desulfolysin [DLY]) and Enterobacter lignolyticus (formerly Enterobacter cloacae

201 We previously isolated Enterobacter lignolyticus strain SCF1, a lignocellulolyt

202 hanism consisting of two adjacent genes from Enterobacter lignolyticus, a rain forest soil bacterium

203 heteroresistance and understand why certain Enterobacter lineages have emerged clinically.

204 r roggenkampii, Enterobacter hoffmannii, and Enterobacter ludwigii was investigated in primary human

205 cteria identified in field-collected H. zea, Enterobacter ludwigii, induced expression of the tomato

206 immunized with this alpha-1,3-glucan-bearing Enterobacter (MK7) are protected against cockroach aller

207 , Serratia marcescens, Vibrio vulnificus and Enterobacter nimipressuralis.

208 iation was identified in rates of BSI due to Enterobacter or Serratia species.

209 Three of these were Enterobacter (Pantoea) species and four of these were Sh

210 at the genus level: Escherichia, Klebsiella, Enterobacter, Pseudomonas, and Stenotrophomonas.

211 at the genus level: Escherichia, Klebsiella, Enterobacter, Pseudomonas, and Stenotrophomonas.

212 ential surface colonizers such as Aeromonas, Enterobacter, Pseudomonas, and Thauera.

213 Bacillus and Enterobacter related sequences showed highest levels of

214 robacter kobei, Enterobacter xiangfangensis, Enterobacter roggenkampii, Enterobacter hoffmannii, and

215 97 cefiderocol-resistant isolates-primarily Enterobacter roggenkampii, Klebsiella oxytoca, Serratia

216 Enterobacter sakazakii (ES) is an emerging pathogen that

217 In 1994, an outbreak of Enterobacter sakazakii infections occurred in a neonatal

218 Enterobacter sakazakii is an emerging pathogen that has

219 The phylogenetic relationships of Enterobacter sakazakii strains were investigated using 1

220 Enterococcus aerogenes, Proteus vulgaris and Enterobacter sakazakii) bacteria, with decoction present

221 Cronobacter (previously known as Enterobacter sakazakii) is a diverse bacterial genus con

222 Enterobacter sakazakii, a common contaminant of milk-bas

223 vehicle for an emerging foodborne pathogen, Enterobacter sakazakii, resulting in high mortality rate

224 Phylogenomic analysis of 3 genera, Enterobacter, Serratia, and Elizabethkingia, reveal line

225 Imaging of fluorescently labeled Enterobacter showed that TGFbeta/BMP-exerted control ope

226 rant mechanisms between Pb(2+) and Cd(2+) in Enterobacter sp.

227 Enterobacter sp. A11 and Comamonas sp. A23 were isolated

228 E. coli and the Enterobacter sp. achieved high populations in hemolymph,

229 er per os challenge with exogenous bacteria (Enterobacter sp. and Serratia marcescens strain Db11) an

230 exodon) was hydrolysed and used to cultivate Enterobacter sp. C2361 and Providencia sp. C1112 for the

231 On the other hand, the Enterobacter sp. C2361 produced lower MTGase activity (1

232 on and production of formic acid showed that Enterobacter sp. had a higher tolerant concentration of

233 on and production of formic acid showed that Enterobacter sp. had a higher tolerant concentration of

234 In an infection with an Enterobacter sp. isolate producing Klebsiella pneumoniae

235 sentinel occurrence of an infection with an Enterobacter sp. isolate producing KPC-4 and NDM-1 in th

236 rant mechanisms between Pb(2+) and Cd(2+) in Enterobacter sp. Microbial respiration and production of

237 e GH8 from the cellulose synthase complex of Enterobacter sp. R1, for deconstruction of beta-glucans.

238 Enterobacter sp. SA187 is a root endophytic bacterium th

239 a soft agar plate, a novel bacterial strain Enterobacter sp. SM3 in swarming and planktonic states e

240 characterized a natural bacterial endophyte, Enterobacter sp. strain PDN3, of poplar trees, that rapi

241 cticidal activity, and reestablishment of an Enterobacter sp. that normally resides in the midgut mic

242 An isolate of Enterobacter sp. was obtained from the microbial communi

243 taphylococci, 1 Enterococcus faecalis, and 1 Enterobacter sp.) on terminal subculture of the AER bott

244 d a root-inhabiting bacterial endophyte, M6 (Enterobacter sp.).

245 we report observations on Escherichia coli, Enterobacter sp., Pseudomonas aeruginosa, and Bacillus s

246 Klebsiella, Acinetobacter, Pseudomonas, and Enterobacter species (ESKAPE) pathogen linked to healthc

247 d extended-spectrum beta-lactamase-producing Enterobacter species [5]).

248 an Ab to microbial alpha-1,3-glucan binds an Enterobacter species and cockroach allergen.

249 Carbapenem-resistant Enterobacter species are emerging nosocomial pathogens.

250 Pathogenic Enterobacter species are of increasing clinical concern

251 Enterobacter species are opportunistic, multidrug resist

252 ree hundred sixty-eight patients experienced Enterobacter species bacteremia and received at least 1

253 We reviewed all cases of Enterobacter species bacteremia at 2 academic hospitals

254 efficacy as carbapenems for the treatment of Enterobacter species bacteremia.

255 tics among patients with K. aerogenes versus Enterobacter species bloodstream infections (BSI).

256 provide experimental evidence of pathogenic Enterobacter species gaining antibiotic resistance via l

257 tation of polymyxin susceptibility tests for Enterobacter species should be undertaken with extreme c

258 t with P. aeruginosa, Klebsiella species, or Enterobacter species susceptible to one of the marker an

259 acter baumannii, Pseudomonas aeruginosa, and Enterobacter species(ESKAPE) and P. aeruginosa pathogens

260 acter baumannii, Pseudomonas aeruginosa, and Enterobacter species) pathogens in particular.

261 piperacillin-tazobactam in P. aeruginosa and Enterobacter species).

262 in Escherichia coli, Klebsiella pneumoniae, Enterobacter species, and Pseudomonas aeruginosa.

263 For polymyxin susceptibility testing of Enterobacter species, close attention must be paid to th

264 ae (Klebsiella pneumoniae, Escherichia coli, Enterobacter species, etc.), Pseudomonas aeruginosa, and

265 This revealed a bloom, specifically of Enterobacter species, in immune-compromised TGFbeta/BMP

266 f oral pathobionts, including Klebsiella and Enterobacter species, in the oral cavity.

267 oorly, especially among Escherichia coli and Enterobacter species.

268 Erwinia rhapontici, Pantoea agglomerans, and Enterobacter species.

269 cherichia coli, Acinetobacter baumannii, and Enterobacter species.

270 ere found in Klebsiella, Mixta, Serratia and Enterobacter species.

271 therapeutics targeting infections caused by Enterobacter species.

272 osa, 174 for Klebsiella species, and 106 for Enterobacter species.

273 Enterobacter spp clinical isolates can persist without r

274 verse species (predominantly Klebsiella spp, Enterobacter spp, and Escherichia coli); 86% (72 of 84)

275 e, or intra-abdominal fluid cultures growing Enterobacter spp, Serratia spp, or Citrobacter spp were

276 ttle is known about the infection biology of Enterobacter spp, we investigated the intracellular traf

277 licobacter pylori, Enterococcus faecium, and Enterobacter spp.

278 k of ESBL-producing Klebsiella pneumoniae or Enterobacter spp.

279 Enterobacter spp. and Escherichia coli isolates harborin

280 15%; n = 109 and n = 88, respectively) than Enterobacter spp. and Escherichia coli isolates harborin

281 ically relevant class C beta-lactamases from Enterobacter spp. and Pseudomonas aeruginosa.

282 cr genes in a range of bacterial species: 46 Enterobacter spp. and single isolates of; Shigella, E. c

283 ants carrying abnormal flora Pseudomonas and Enterobacter spp. predominated.

284 f all Escherichia coli, Klebsiella spp., and Enterobacter spp. tested by MicroScan at this laboratory

285 acter baumannii, Pseudomonas aeruginosa, and Enterobacter spp. were analyzed for their association wi

286 acter baumannii, Pseudomonas aeruginosa, and Enterobacter spp.) directly from infected wounds in 3D i

287 e, A. baumannii, Pseudomonas aeruginosa, and Enterobacter spp.).

288 scens, 5/6 with Citrobacter spp., 13/14 with Enterobacter spp., 23/24 with E. coli, 2/3 with K. oxyto

289 neumoniae, 92.9%; Klebsiella oxytoca, 95.5%; Enterobacter spp., 99.3%; Pseudomonas aeruginosa, 98.9%;

290 pp., Klebsiella spp., Staphylococcus aureus, Enterobacter spp., and Pseudomonas spp.) in 195 countrie

291 robacter koseri, Citrobacter freundii group, Enterobacter spp., and Serratia marcescens.

292 rgets (Acinetobacter spp., Citrobacter spp., Enterobacter spp., Escherichia coli/Shigella spp., Klebs

293 GA) metropolitan area, all Escherichia coli, Enterobacter spp., or Klebsiella spp. resistant to >=1 c

294 dred consecutive, single patient isolates of Enterobacter spp., Serratia spp., Citrobacter spp., and

295 antly Escherichia coli, Klebsiella spp., and Enterobacter spp., with counts up to 10(8) CFU/g.

296 s), the second by Proteobacteria (Klebsiella/Enterobacter), the third by Bacteriodetes, and the fourt

297 nera Acinetobacter, Pseudomonas, Klebsiella, Enterobacter, Vibrio, Shigella, Salmonella, Yersinia, My

298 Our understanding of Enterobacter virulence is limited, hindering the develop

299 including Streptomyces, Stenotrophomonas and Enterobacter was negatively correlated with that of Melo

300 Enterococcus, Escherichia-Shigella, and Enterobacter were instead the keystones detected in the

301 nterobacter bugandensis, Enterobacter kobei, Enterobacter xiangfangensis, Enterobacter roggenkampii,